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Abstract
Background: The aim of our study was to assess the suitability of different interventional
techniques to create an atrial septal defect (ASD) and to evaluate the short-term effects of right
ventricular (RV) volume overload on RV contractility in the growing swine.
Methods: Thirteen ASD and six control animals were studied. An ASD was created by
balloon dilatation (BD) of the fossa ovalis (n = 4) or by implantation of a multi-perforated
Amplatzer Septal Occluder (n = 4) or a patch-less nitinol device (n = 5). After 4.8 (3.9–6.0)
weeks, the amounts of left-to-right shunting (Qp/Qs) and RV contractility (end systolic elastance
— Ees) were assessed.
Results: In the ASD group, a significant left-to-right shunt could be documented (Qp/Qs 1.5 ±
± 0.4). However, a shunt was absent in the BD subgroup (Qp/Qs 1.1 ± 0.1). In animals with
devices implanted, a significant relationship between the post-mortem ASD area and Qp/Qs
was found (r = 0.68, p < 0.05). Compared to controls, RV contractility was not significantly
impaired at rest and during dobutamine in ASD animals (Ees: 0.40 ± 0.20 vs 0.54 ± 0.12
and 0.75 ± 0.29 vs 1.04 ± 0.24 mm Hg/mL, p = NS for both).
Conclusions: Device implantation is necessary to create a patent ASD resulting in signifi-
cant left-to-right shunting. In an experimental ASD model, a five week period of chronic RV
volume overload does not alter RV contractility significantly. (Cardiol J 2011; 18, 3: 289–296)
Key words: atrial septal defect, right ventricular volume load, right ventricular
function
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Introduction
Many congenital heart lesions are associated
with long-standing right ventricular (RV) volume
overload, and it has become apparent that RV volu-
me overload can lead to irreversible RV dysfunc-
tion later in life [1, 2]. RV volume overload can be
caused by pulmonary regurgitation, which has been
found to be the major determinant of long-term
outcome in patients after repair of tetralogy of Fal-
lot [3]. Clinical and experimental data suggest that,
in the presence of pulmonary regurgitation, RV
dysfunction ensues early in life [4, 5].
RV volume overload can also be caused by left-
-to-right shunting across an atrial septal defect
(ASD). In these patients, RV reverse remodeling
with normalization of RV volumes is well document-
ed for pediatric and adult patients, and normal long
term prognosis can be achieved so long as ASD clo-
sure is performed within the first two decades of
life [6, 7]. However, no data exists about the prese-
nce of any early RV dysfunction in the presence of
an ASD. To answer this question, we decided to
develop an animal model of RV volume overload to
investigate the early effects of atrial right-to-left
shunting on load independent RV myocardial func-
tion (i.e. contractility) using the pressure-volume
conductance system in the growing swine. Further-
more, we sought to compare the suitability of dif-
ferent interventional techniques to create a patent
and significant atrial septal communication.
Methods
Study protocol
Nineteen pigs (German Landrace) were en-
rolled in the study. All animals underwent two ex-
perimental cardiac catheterization studies, includ-
ing an initial experiment (cardiac catheterization
study 1) with full hemodynamic assessment with or
without creation of an ASD (ASD group and con-
trol group, respectively). A second cardiac cathe-
terization study was performed a median of 4.8
(3.9–6.0) weeks later, again with hemodynamic as-
sessment and RV function analysis using the pres-
sure-volume conductance system (cardiac cathete-
rization study 2). The protocol is summarized in
Figure 1. The mean animal weight at the first study
was 25.2 ± 1.0 kg and had increased to 40.0 ± 6.2 kg
at the final experiment, with no difference between
groups.
The treatment of the animals followed the
guidelines in the Guide for the Care and Use of
Laboratory Animals. The protocol was approved by
the animal research committee of the Christian-
-Albrechts-University of Kiel, Germany (reference
number: V 742-72241.121-24).
Cardiac catheterization study 1
This initial study was performed under seda-
tion with the animal breathing spontaneously. Seda-
tion was initiated with the use of azaperone (2 mg/kg
IM) and maintained with ketamine (1–2 mg/kg IV)
given on demand. Venous and arterial punctures
were performed under local anesthesia.
Creation of an atrial septal defect. In 13 ani-
mals (‘ASD group’), an ASD was created by balloon
dilatation (BD) of the fossa ovalis using a 24 mm
balloon catheter (AGA Medical Corporation, Ply-
mouth, MN, USA). In four animals, no additional
intervention was performed (‘BD group’). In anoth-
er four pigs, a custom-made modified Amplatzer
Septal Occluder with a 10 mm waist containing four
5 mm holes (Prof. Kurt Amplatz, AGA Medical Cor-
poration, Plymouth, MN, USA) was placed in the
defect (‘Amplatzer group’). In an additional five
animals, a self-made device cut from a single niti-
nol tube (Dr. Franz Freudenthal, La Paz, Bolivia)
was implanted (‘SM group’). This device contains
five nitinol struts that after deployment form into
two retention discs with a central 15 mm waist to
self-centre in the defect.
A group of six pigs served as controls (‘control
group’). These animals were age matched with the ASD
group and underwent the first cardiac catheterization
study solely to obtain hemodynamic data (Fig. 1).
Hemodynamic measurements. Cardiac pres-
sures were measured with catheters connected to
a fluid-filled pressure transducer. Pressures were
measured in the right atrium, RV and main pulmo-
nary artery. Blood samples were taken for oximetry
from the superior (SVC) and inferior vena cava (IVC),
the main pulmonary artery and the femoral artery.
The ratio of pulmonary to systemic blood flow
(Qp/Qs) was calculated according to the formula:
where SatArt is the arterial oxygen saturation,
SatMV is the mixed venous saturation, SatPA is the
pulmonary artery oxygen saturation and SatPV is
the pulmonary venous oxygen saturation. SatPV
was assumed to be similar to SatArt or 98% in case
SatArt was lower than this and normal pulmonary
gas exchange could be documented. SatMV was
calculated according the formula:
SatPASatPV
SatMVSatArtQsQp
−
−
=/
( ) 2/SatIVCSatSVCSatMV +=
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where SatSVC and SatIVC are the oxygen satura-
tion in the SVC and the IVC, respectively.
Cardiac catheterization study 2
This study was performed under general ane-
sthesia. Anesthesia was initiated with azaperone
(2 mg/kg IM) and propofol (4–6 mg/kg IV). After in-
tubation, the animals were mechanically ventilated
with room air using a volume-controlled ventilator
(Siemens Servo 900C, Siemens AG, Erlangen, Ger-
many). General anesthesia/analgesia was main-
tained with propofol (10–20 mg/kg/h IV) and fenta-
nyl (6–8 μg/kg/min IV).
Conductance study. Once hemodynamic data
similar to that in study 1 was collected, including
Qp/Qs calculation, a 4 F combined pressure-conduc-
tance catheter with 12 electrodes (CD Leycom,
Zoetermeer, The Netherlands) was placed in the RV
via the inferior caval vein in order to acquire RV pres-
sure-volume loops. Pressure-volume signals were
displayed online and digitized at a sample rate of
250 Hz (CFL 512, CD Leycom, Zoetermeer, The
Netherlands). The pressure signal was calibrated with
a standard calibration pulse from the amplifier (Sen-
tron, Roden, The Netherlands). Conductance derived
RV volume was calibrated for blood resistivity, gain
factor a and parallel conductance using thermodilu-
tion for cardiac output measurement and venous hy-
pertonic saline injections [8, 9]. A 35 mm latex bal-
loon catheter (AGA Numed, Hopkinton, NY, USA)
was placed at the junction of the IVC and the right
atrium and prepared to modify preload. Pressure vo-
lume data was recorded for 10–15 s with the respira-
tor temporarily interrupted at end expiration. Pres-
sure and volume signals were collected along with the
ECG during steady state conditions and progressive
vena caval occlusion to generate pressure-volume
loops over a wide range of filling pressures. Measure-
ments were repeated at the end of a ten minute infu-
sion of 10 μg/kg/min of dobutamine. All data acquisi-
tion runs were repeated in triplicate and all runs con-
taining premature ventricular contractions were
excluded from analysis. Volume calibrations were per-
formed at baseline and during dobutamine infusion.
Post-mortem analysis of ASD size. At the
end of study 2, the animals were euthanized by an
intravenous injection of 40 mL potassium chloride,
and the heart was then excised. The patency of the
atrial septum was evaluated and the size of the defect
was quantified from digital images by digital planime-
try using standard software (Adobe Photoshop 9.0,
Adobe Systems Inc, San Jose, CA, USA).
Calculations
Analysis of pressure volume loops was per-
formed with custom-made software (Circlab 2008).
Steady state hemodynamic data was calculated from
pressure-volume loop recordings at baseline and
after dobutamine infusion as means of all beats dur-
ing a ten-second period.
Heart rate, cardiac output, stroke volume, end
diastolic volume (EDV) and end systolic volume
(ESV), RV ejection fraction (EF), end systolic and
end diastolic pressure (ESP and EDP), maximal and
minimal rate of RV pressure change (dP/dtmax, dP/
/dtmin) were analyzed. The time constant of relaxa-
tion (t), reflecting the early active relaxation pro-
cess, was calculated as the time constant of mo-
noexponential pressure decay during isovolumic re-
laxation. The isovolumic period was defined as the
period between the time point of dP/dtmin and the
time point at which dP/dt reached 10% of the dP/
/dtmin value. Stroke work (SW) was calculated as the
area enclosed by the pressure-volume loop.
Figure 1. Study protocol; ASD — atrial septal defect; RV — right ventricular.
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Indices of systolic and diastolic function were
derived from pressure-volume loops recorded dur-
ing the preload reduction maneuver. For systolic
function, we determined end systolic elastance
(Ees) as the slope of the end systolic pressure-vo-
lume relationship (ESPVR: ESP vs ESV) and the
slope (Mw) of the preload recruitable stroke work
relation (PRSW; SW vs EDV). Diastolic stiffness
(Eed) was determined as the slope of the end dias-
tolic pressure-volume relationship (EDPVR: EDP
vs EDV). These slopes are regarded as the optimal
load-independent indices of intrinsic systolic (Ees)
and diastolic (Eed) ventricular function, reflecting
contractility and lusitropy, respectively [10, 11].
All functional data was evaluated by an inves-
tigator blinded to the group affiliation of the respec-
tive animal.
Statistical analysis
Differences in baseline and dobutamine hemo-
dynamic and functional parameters between the
control group and the ASD group were analyzed
using an unpaired Student’s t-test. The effects of
dobutamine infusion on hemodynamic parameters
were analyzed for each group using a paired Stu-
dent’s t-test. Comparison of Qp/Qs and ASD size
between the three different subgroups of the ASD
group were made by a Kruskal-Wallis test. If the
Kruskal-Wallis test yielded a p < 0.05, post-hoc
pairwise comparison of subgroups was performed
using the Wilcoxon test. Univariate regression ana-
lyses were used to assess associations between
continuous variables.
A p value < 0.05 was considered statistically
significant except for within- and between-group
comparisons of baseline and dobutamine hemody-
namic and functional data, where the significance
level was adjusted to p < 0.003 as the effects on
15 parameters were tested.
Results
ASD area and Qp/Qs
The data on ASD area and Qp/Qs for the three
subgroups of the ASD group is set out in Figure 2.
Overall, in the ASD group, the initial experi-
ment resulted in a significant left-to-right shunt
with an increase in Qp/Qs from 1.0 ± 0.2 to 1.5 ±
± 0.4 at the second study (p < 0.001). However,
BD of the fossa ovalis alone (BD group) failed to
induce a significant left-to-right shunt, even though
a considerable defect was present in these animals
on post-mortem examination (Fig. 3). The ASD area
in the BD group was similar to that of the Amplatzer
group, but only in the latter could a significant left-
-to-right shunt be documented by oximetry. The
group of animals with a self-made device (the SM
group) had the largest ASD area on post-mortem
analysis and correspondingly the largest left-to-
-right shunt.
There was a significant linear relationship be-
tween the post-mortem ASD area and Qp/Qs at the
final experiment when excluding the animals from
the BD group from this analysis (r = 0.68; p < 0.05).
ASD morphology
Gross examination of the implanted devices
revealed unobstructed holes of the Amplatzer de-
vice and no obstruction of the meshwork of the self-
made device, with only minimal intimal hyperpla-
sia and without any superficial deposition of throm-
bus material. Full endothelialization of the
Amplatzer device was obvious on macroscopic exa-
mination. The metal struts of the self-made nitinol
device partly appeared uncovered by endothelium
(Fig. 3). The defect area in the Amplatzer group was
0.75 ± 0.2 cm2, exactly in the range of the expected
area of four 5 mm holes, which is 0.78 cm2. This
result indicates that no significant intimal hyperpla-
sia obstructed the holes of the device. With an area
of 1.31 ± 0.38 cm2, the defects were largest in the
SM group, but considerably smaller than the area
Figure 2. Atrial septal defect (ASD) area and Qp/Qs.
Balloon dilatation only (white column) failed to produce
a significant left-to-right shunt, although a considerable
defect was visible on post-mortem inspection of the
interatrial septum. The largest defect (and correspon-
dingly the largest shunt) was achieved by implantation
of the self-made, patch-less nitinol device (black co-
lumn). The grey dotted lined represents a Qp/Qs of 1.0
indicating the absence of any intracardiac shunting;
*p < 0.05 Amplatzer and SM group vs BD group on
post-hoc pairwise comparison of subgroups using the
Wilcoxon test.
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theoretically achievable by a device with a 15 mm
waist, which is 1.77 cm2. This difference, and the
wide scatter of defect area in the SM group (ran-
ging from 0.91 to 1.64 cm2), indicate that this de-
vice does not allow an accurate prediction of the
post-procedural ASD size. The variability in ASD
size observed after implantation of the SM device
results from the fact that in some cases the rim of
the defect was not fully clamped by the waist of the
device (Fig. 4).
Hemodynamics and RV function
RV hemodynamic and functional parameters at
baseline and during dobutamine infusion are given
in Table 1.
Creation of an ASD with induction of signifi-
cant left-to-right shunt did lead to a mild increase
in EF in the ASD group, both at baseline and du-
ring dobutamine infusion. However, this increase
only mirrors a non-significant increase in SV cor-
responding with a non-significant decrease in ESV
in the ASD group. As heart rate tended to be lower
in the ASD group under both conditions, cardiac
output was similar between control animals and
those with an ASD.
Figure 3. Atrial septal defect (ASD) devices and morphology. Creation of an ASD with balloon dilatation of the fossa
ovalis only (A) and by implantation of custom-made Amplatzer device (B, C) or a patch-less self-made nitinol device
(D, E). Both devices remained patent, creating a significant left-to-right shunt and no intimal hyperplasia was present
on macroscopic inspection 4.8 weeks after implantation.
Balloon dilatation Amplatzer device Self−made device
Figure 4. Right atrial aspect of a self-made device im-
planted to create a persisting atrial septal defect. The
rim of the defect was not fully clamped by the waist of
the device, resulting in the smallest defect area in the
SM group of 0.91 cm2.
The ESP was mildly lower in the control group
at baseline but not during dobutamine infusion. The
EDP tended to be lower in the ASD group under
dobutamine infusion only.
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Load-dependent indices of RV function such as
dP/dtmax and SW increased similarly with dobu-
tamine in both groups.
The time constant of isovolumic relation was
also similar between groups during baseline and
dobutamine recordings.
The load independent indices of RV myocar-
dial contractility, Ees and Mw, increased similarly
in both groups with dobutamine infusion. Compari-
son of these indices at both conditions did not re-
veal any significant difference between control and
ASD animals.
There was no correlation between the amount
of left-to-right shunting (Qp/Qs) and the indices of
load independent RV function in the group of ani-
mals with an ASD (Qp/Qs vs Ees: r = 0.27, p = 0.25;
Qp/Qs vs Mw: r = 0.29, p = 0.37). Such a relation-
ship was also absent when calculated for animals
with a Qp/Qs greater than 1.5, even though a trend
towards an impaired RV end systolic elastance (Ees)
with increasing Qp/Qs was found in this subgroup
(Qp/Qs vs Ees: r = –0.50, p = 0.08).
Diastolic stiffness, Eed, was similar between
groups at both conditions and did not change with
dobutamine infusion.
Discussion
In this experimental animal study, we demon-
strated that device implantation is necessary to at-
tain significant shunting across an interatrial com-
munication produced by BD of the fossa ovalis. We
also found that RV volume overload from atrial left-
-to-right shunting does not alter right heart hemo-
dynamics or RV contractility within a period of about
five weeks.
Technique of ASD creation
The magnitude and direction of flow through
any ASD depend on the size of the defect and the
relative diastolic filling properties of the left and
right ventricles. Looking at the ASD size in the
three subgroups of animals in whom an ASD was
created, one would therefore expect a significant
left-to-right shunt also in the group of animals who
received a BD solely of the fossa ovalis. The post-
mortem ASD area in this group was comparable to
those animals in which a perforated Amplatzer de-
vice was implanted (Fig. 2). The fact that even so
no shunt across the septum could be demonstrated
by oximetry about five weeks after the intervention
may indicate a discrepancy between the defect size
on post-mortem analysis, and the effective defect
size in the beating heart of animals with a defect
resulting from BD alone. ASD size does vary
throughout the cardiac cycle with a maximum at end
systole and a minimum at end diastole [12, 13].
A more slit-like and unsplinted defect may well be
small or nearly closed during diastole, when flow
across the defect would be maximal [14].
Certain congenital heart defects require the
creation of an unrestrictive ASD to relieve atrial hy-
pertension, to maintain systemic cardiac output, or
to achieve adequate atrial mixing to improve syste-
mic oxygen saturation. We describe an interventio-
nal method to create such defects and show that
device implantation is mandatory in case a defect is
desired that allows significant left-to-right shunting.
After a period of five weeks, we found the per-
forated Amplatzer device fully endothelialized and
without significant intimal hyperplasia. As opposed
to the SM device, the area of the defect created by
the Amplatzer device was nearly exactly that theo-
retically expected from its design. This finding sug-
gests that this device is particularly suitable in pro-
ducing a permanent ASD of a predictable size. The
Amplatzer device is a modified Amplatzer Septal
Occluder with a similar, well-established implanta-
tion procedure [15]. The design of this device would
also allow alternative modifications with holes of
varied number and size.
Our self-made nitinol device did not seem to
be entirely covered by endothelium on gross inspec-
tion. However, a thin but complete endothelial lay-
er on the surface of the implant might well have
been detectable histologically [16].
RV function in the presence of
atrial left-to-right shunting
Our study was initiated primarily to establish
a pratical experimental model of RV volume over-
load; in this respect, a significant left-to-right shunt
on atrial level should be created. This goal was
achieved in the ASD group with a mean Qp/Qs of
1.5 ± 0.4 after a five week follow-up period.
The amount of this volume overload equals that
of severe pulmonary insufficiency with a regurgitant
fraction of 50%. However, no impact on RV contrac-
tility either at baseline or during dobutamine infu-
sion could be found. This result is at odds with the
effect of pulmonary insufficiency on the RV in
a comparable animal model of the growing swine re-
ported by Kuehne et al. [5]. Differences in study
protocol are probably responsible for this. Firstly,
the animals in our study were older and therefore
heavier, with a weight of 25 kg at the beginning of
the study as opposed to 13.9 kg. Secondly, the time
period between the initial experiment with initia-
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tion of RV volume overload and the RV function
study was considerably shorter (4.8 vs 12 weeks on
average). This difference might well explain the
absence of any impact of RV volume overload on
RV contractility in our investigation. However,
whether an extension of the follow-up period and
a creation of an ASD earlier in life would result in
a comparable impairment in RV contractility, or
whether an RV responds fundamentally differently
to volume overload resulting from pulmonary back-
flow as opposed to an increased trans-tricuspid inflow
remains to be elucidated by additional experiments.
Limitations of the study
As the bread of swine used in our study is grow-
ing fastly, we chose a follow-up interval of only five
weeks when planning the study. As discussed
above, this interval might have been too short to
detect any late impact of atrial left-to-right shunt-
ing on intrinsic RV function.
Nowadays, cardiac magnetic resonance imag-
ing is the method of choice to determine RV volu-
metric data. We did not use this method in the
present study and therefore cannot compare the
volumes obtained by the conductance system to this
gold standard. However, the conductance technique
is regarded as the best available method to analyse
load-independent ventricular function, which was
the main intention of this study.
The conductance technique was developed to
obtain pressure-volume loops in the more eliptically
shaped left ventricle, and may be less accurate in
the RV. Nevertheless, serial validation studies have
shown that it can also be applied with accuracy in
the RV [17, 18].
Conclusions
The present study shows that BD of the fossa
ovalis alone is not sufficient to create a persisting
atrial communication leading to significant transsep-
tal blood flow, and that device implantation is ne-
cessary as an additional procedure to achieve this
goal. Furthermore, it shows that RV volume over-
load from atrial left-to-right shunting does not al-
ter right heart hemodynamics or intrinsic RV func-
tion within a period of five weeks in an experimen-
tal model of the growing swine.
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